Taiwan Semiconductor
TSM
NVIDIA
NVDA
Advanced Micro Devices
AMD
4
Adobe
ADBE
5
Meta Platforms
META
US Stock MarketDetailed Quotes
CRVS Corvus Pharmaceuticals
- 4.210
- -0.210-4.75%
Close Mar 20 16:00 ET
- 4.760
- +0.550+13.06%
Post 16:40 ET
270.52MMarket Cap-4.25P/E (TTM)
4.600High4.190Low651.80KVolume4.340Open4.420Pre Close2.79MTurnover1.44%Turnover RatioLossP/E (Static)64.26MShares10.00052wk High21.81P/B190.12MFloat Cap1.30052wk Low--Dividend TTM45.16MShs Float22.137Historical High--Div YieldTTM9.28%Amplitude0.607Historical Low4.287Avg Price1Lot Size
Corvus Pharmaceuticals Key Stats
EPS
According to the latest financial report of Corvus Pharmaceuticals, the latest earnings per share (TTM) for the company is -0.60. Investing in companies with strong earnings per share can potentially provide higher returns.
Currency: USD
Quarterly
Loading...
FCF
Interested in knowing about Corvus Pharmaceuticals's free cash flow? The latest report shows it as -6.32M. Keep an eye on and closely monitor the company's cash flow to make informed investment decisions.
Currency: USD
Quarterly
Loading...
Current Ratio
If you are evaluating a company's liquidity, current ratio is an important measure to consider. The latest financial report of Corvus Pharmaceuticals shows that the company's current ratio is 0.92, indicating healthy liquidity.
Currency: USD
Quarterly
Loading...
Quick Ratio
Another liquidity indicator to closely monitor is quick ratio. According to the latest financial results of Corvus Pharmaceuticals, the quick ratio is 0.90, indicating that the company can meet its short-term debt obligations.
Currency: USD
Quarterly
Loading...
ROE
Want to learn more about the financial health of Corvus Pharmaceuticals? The latest ROE figure is -126.40%, indicating that the company has stable profitability.
Currency: USD
Quarterly
Loading...
ROA
Investors looking for profitability indicators may be interested in ROA. According to the latest financial results of Corvus Pharmaceuticals, the total asset return on investment (ROA) is -65.19%.
Currency: USD
Quarterly
Loading...
Gross Margin
Gross margin can provide insight into a company's pricing strategy and cost structure. Check Corvus Pharmaceuticals's latest financial report to see how their gross margin is doing - currently at --.
Currency: USD
Quarterly
Loading...
Net Margin
For investors focusing on operational efficiency, net profit margin is an important indicator. According to the latest financial results of Corvus Pharmaceuticals, the net profit margin is --, which is a good sign for its profitability.
Currency: USD
Quarterly
Loading...
Market Insights
U.S Tech Companies U.S Tech Companies
U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data. U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data.
Unlock Now
Discussing
Trump 2.0 Era: How will global markets evolve?
🎙️Discussion: 1. How will tariff policies affect the movement of key assets such as U.S. stocks, gold, and Bitcoin? 2. Given this context,
Moo Live
Jan 23 16:54
MicroStrategy Q4 2024 earnings conference call